DEF 14A

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

July 19, 2024

Period of Report

May 28, 2023

Accession Number

0001005286-24-000090

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →